[go: up one dir, main page]

PE20080175A1 - Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico - Google Patents

Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico

Info

Publication number
PE20080175A1
PE20080175A1 PE2007000348A PE2007000348A PE20080175A1 PE 20080175 A1 PE20080175 A1 PE 20080175A1 PE 2007000348 A PE2007000348 A PE 2007000348A PE 2007000348 A PE2007000348 A PE 2007000348A PE 20080175 A1 PE20080175 A1 PE 20080175A1
Authority
PE
Peru
Prior art keywords
malate
quinolincarboxyl
metoxy
piperidinyl
cyclopropyl
Prior art date
Application number
PE2007000348A
Other languages
English (en)
Inventor
Nancy Lee Redman-Furey
Jane Ellen Godlewski
Michael Lloyd Dieks
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38441484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080175(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE20080175A1 publication Critical patent/PE20080175A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SE REFIERE A SALES POLIMORFICAS DE MALATO DE (3S,5S)-7-[3-AMINO-5-METIL-PIPERIDINIL]-1-CICLOPROPIL-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLINCARBOXILICO QUE COMPRENDE DE 0% A 5% DE AGUA EN PESO, Y PRESENTA PICOS CARACTERISTICOS DE DIFRACCION DE RAYOS X A APROXIMADAMENTE 9,3; 12,1 Y 22,6 GRADOS 2 THETA, SIENDO SELECCIONADAS LAS SALES POLIMORFAS: D,L-MALATO SEMIHIDRATADO, D-MALATO HIDARATADO, L-MALATO HIDRATADO, D-MALATO ANHIDRO Y L-MALATO ANHIDRO. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE LO COMPRENDE PARA TRATAR O PREVENIR UN TRASTORNO INFECCIOSO
PE2007000348A 2006-03-28 2007-03-28 Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico PE20080175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78648306P 2006-03-28 2006-03-28

Publications (1)

Publication Number Publication Date
PE20080175A1 true PE20080175A1 (es) 2008-03-14

Family

ID=38441484

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000348A PE20080175A1 (es) 2006-03-28 2007-03-28 Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico

Country Status (27)

Country Link
US (1) US8039485B2 (es)
EP (1) EP2001862B1 (es)
JP (1) JP5097967B2 (es)
KR (1) KR101102288B1 (es)
AR (2) AR060189A1 (es)
AT (1) ATE507219T1 (es)
AU (1) AU2007230630B2 (es)
BR (1) BRPI0709772B8 (es)
CA (1) CA2647346C (es)
CY (1) CY1111683T1 (es)
DE (1) DE602007014191D1 (es)
DK (1) DK2001862T3 (es)
ES (1) ES2366150T3 (es)
HR (1) HRP20110558T1 (es)
IL (1) IL193990A (es)
MA (1) MA30554B1 (es)
MX (1) MX2008012328A (es)
MY (1) MY148393A (es)
NZ (1) NZ570494A (es)
PE (1) PE20080175A1 (es)
PL (1) PL2001862T3 (es)
PT (1) PT2001862E (es)
SI (1) SI2001862T1 (es)
SM (1) SMP200800058B (es)
TW (1) TWI364419B (es)
WO (1) WO2007110834A2 (es)
ZA (1) ZA200807158B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008012488A (es) * 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
EA018653B1 (ru) * 2008-07-01 2013-09-30 Тайджен Байотекнолоджи Ко., Лтд. Лечение инфекций, вызванных антибиотикоустойчивыми бактериями
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
US8553466B2 (en) 2010-03-04 2013-10-08 Samsung Electronics Co., Ltd. Non-volatile memory device, erasing method thereof, and memory system including the same
CZ304984B6 (cs) 2012-10-12 2015-03-11 Zentiva, K.S. Zlepšený způsob výroby a nové intermediáty syntézy elvitegraviru
CZ304983B6 (cs) * 2012-10-12 2015-03-11 Zentiva, K.S. Způsob výroby a nové intermediáty syntézy elvitegraviru
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
CN114437026A (zh) * 2021-10-26 2022-05-06 浙江医药股份有限公司新昌制药厂 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法
CN116332831B (zh) * 2023-03-15 2025-10-28 浙江医药股份有限公司新昌制药厂 氨基被Boc保护的3-氨基-5-甲基哌啶的提纯方法

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017622A (en) 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
JPS5186476A (en) 1975-01-17 1976-07-29 Yoshitomi Pharmaceutical Shinkina kinoronkarubonsanjudotaino seiho
JPS5845426B2 (ja) 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS604820B2 (ja) 1979-02-26 1985-02-06 大塚製薬株式会社 キノリンカルボン酸誘導体
JPS5649382A (en) 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
IE55898B1 (en) 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US5281612A (en) 1982-09-09 1994-01-25 Warner-Lambert Company Naphthyridine antibacterial agents
DE3248506A1 (de) 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4994599A (en) 1987-11-20 1991-02-19 Abbott Laboratories Intermediates for producing quinolone-3-carboxylic acids
JPS60221484A (ja) 1984-04-17 1985-11-06 Fuji Photo Film Co Ltd 放射線像変換方法およびその方法に用いられる放射線像変換パネル
DE3420798A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
US4822801A (en) 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4771054A (en) 1985-01-23 1988-09-13 Warner-Lambert Company Antibacterial agents
JPS61225181A (ja) 1986-02-04 1986-10-06 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法
HUT40639A (en) 1985-03-08 1987-01-28 Kyorin Seiyaku Kk Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them
JPS61205258A (ja) 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法
EP0207420B1 (en) 1985-06-26 1992-05-06 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives
JPS6236377A (ja) 1985-07-03 1987-02-17 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPH089597B2 (ja) 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
DE3705621C2 (de) 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62205060A (ja) 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
JPS62215572A (ja) 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPH0717608B2 (ja) 1986-04-25 1995-03-01 杏林製薬株式会社 ６−アルコキシキノロンカルボン酸誘導体
DE3704907A1 (de) 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
US4780468A (en) 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US4997946A (en) 1987-08-18 1991-03-05 Eastman Kodak Company Process for the iodination of hydroxyaromatic and aminoaromatic compounds
JPH0676400B2 (ja) 1987-08-25 1994-09-28 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
US4921857A (en) 1987-09-18 1990-05-01 Merck & Co., Inc. 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
EP0342675B1 (en) 1988-05-19 1995-01-25 Chugai Seiyaku Kabushiki Kaisha Novel quinolonecarboxylic acid derivatives
JP2844079B2 (ja) 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
AU618823B2 (en) 1988-07-20 1992-01-09 Sankyo Company Limited 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
US5286723A (en) 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
CA2001203C (en) 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5328908A (en) 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
EP0997466A1 (en) 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
HU219403B (hu) 1989-08-16 2001-04-28 Pfizer Inc. Azabiciklo-csoporttal helyettesített kinolon- és naftiridon-karbonsavak és eljárás ezek előállítására
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
EP0443498A1 (en) 1990-02-19 1991-08-28 Kyorin Pharmaceutical Co., Ltd. Isoindoline derivatives
US5116834A (en) 1990-04-12 1992-05-26 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents
ES2150904T3 (es) 1990-05-02 2000-12-16 Abbott Lab Compuestos de tipo quinolizinona.
US5580872A (en) 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
US5599816A (en) 1990-05-02 1997-02-04 Abbott Laboratories Quinolizinone type compounds
JPH0778065B2 (ja) 1990-07-06 1995-08-23 杏林製薬株式会社 （６，７―置換―８―アルコキシ―１―シクロプロピル―１，４―ジヒドロ―４―オキソ―３―キノリンカルボン酸―ｏ▲上３▼，ｏ▲上４▼）ビス（アシルオキシ―ｏ）ホウ素化合物及びその塩並びにその製造方法
US5364861A (en) 1990-11-30 1994-11-15 Warner-Lambert Company Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
US5258528A (en) 1990-11-30 1993-11-02 Warner-Lambert Company Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group
US5072001A (en) 1990-11-30 1991-12-10 Warner-Lambert Company Certain optically active substituted 3-pyrraidine acetic acid derivatives useful as intermediates
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4123918A1 (de) 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
WO1993013091A1 (fr) 1991-12-27 1993-07-08 Wakunaga Seiyaku Kabushiki Kaisha Nouveau derive de quinolone ou sel de ce derive et agent antibacterien contenant ce derive
EP0550016A1 (en) 1991-12-31 1993-07-07 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and processes for preparing same
NO304832B1 (no) 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
DE4230804A1 (de) 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
KR0148277B1 (ko) 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
DE4301245A1 (de) 1993-01-19 1994-07-21 Bayer Ag Fluor-trifluormethylbenzoesäure-Derivate
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
CA2152828A1 (en) 1993-03-16 1994-07-07 Shin-Ichi Uesato 8-methoxy-quinolonecarboxylic acid derivatives
TW252107B (es) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
BR9407806A (pt) 1993-10-14 1997-08-19 Abbott Lab Composto processo de tratamento de uma infecção bacteriana em um paciente humano ou veterinário e intermediário sintético
NZ290946A (en) 1994-08-12 1997-12-19 Toyama Chemical Co Ltd Quinolone- or naphthyridone-carboxylic acid derivatives
JP3745433B2 (ja) 1995-02-02 2006-02-15 第一製薬株式会社 複素環式化合物
CA2212226A1 (en) 1995-02-02 1995-08-10 Katsumi Chiba Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof
PT807630E (pt) 1995-02-02 2003-08-29 Daiichi Seiyaku Co Compostos heterociclicos
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
JPH11510478A (ja) 1995-06-06 1999-09-14 アボツト・ラボラトリーズ キノリジノン型化合物
IT1279532B1 (it) 1995-07-24 1997-12-16 Mediolanum Farmaceutici Spa Derivati chinolonici non fluorurati e loro impiego come agenti antibatterici
JP4040091B2 (ja) 1995-11-22 2008-01-30 第一三共株式会社 置換アミノシクロアルキルピロリジン誘導体
CN1103769C (zh) 1996-10-25 2003-03-26 第一制药株式会社 三环胺衍生物
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
ATE292632T1 (de) 1997-05-21 2005-04-15 Daiichi Seiyaku Co Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
MY119816A (en) 1997-05-30 2005-07-29 Daiichi Seiyaku Co Substituted cyclobutylamine derivatives
KR100241673B1 (ko) 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
IL135036A0 (en) * 1997-09-15 2001-05-20 Procter & Gamble Antimicrobial quinolones, their compositions and uses
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
EA005585B1 (ru) 2000-01-24 2005-04-28 Уорнер-Ламберт Компани 3-аминохиназолин-2,4-дионовые антибактериальные агенты
EP1341781B1 (en) 2000-12-14 2005-09-14 The Procter & Gamble Company Antimicrobial quinolones
JP4250353B2 (ja) 2001-06-22 2009-04-08 エドワーズ株式会社 真空ポンプ
US6900224B2 (en) 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
JP2007522093A (ja) * 2003-09-22 2007-08-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ７−アミノアルキリデニル−複素環式キノロンおよびナフチリドン
US7732612B2 (en) 2004-09-09 2010-06-08 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
MX2008012327A (es) * 2006-03-28 2008-10-09 Procter & Gamble Un proceso de reduccion con hidruro para preparar intermedios de quinolona.

Also Published As

Publication number Publication date
CA2647346C (en) 2011-07-19
IL193990A (en) 2014-12-31
JP5097967B2 (ja) 2012-12-12
RU2417222C2 (ru) 2011-04-27
WO2007110834A3 (en) 2007-12-06
BRPI0709772B1 (pt) 2019-10-15
TWI364419B (en) 2012-05-21
MY148393A (en) 2013-04-15
ZA200807158B (en) 2009-09-30
EP2001862B1 (en) 2011-04-27
AR060189A1 (es) 2008-05-28
DK2001862T3 (da) 2011-08-08
JP2009531417A (ja) 2009-09-03
SMAP200800058A (it) 2008-10-29
BRPI0709772B8 (pt) 2021-05-25
CY1111683T1 (el) 2015-10-07
EP2001862A2 (en) 2008-12-17
AU2007230630B2 (en) 2012-12-20
RU2008134544A (ru) 2010-05-10
BRPI0709772A2 (pt) 2011-07-26
MX2008012328A (es) 2008-10-09
PT2001862E (pt) 2011-07-20
US8039485B2 (en) 2011-10-18
WO2007110834A2 (en) 2007-10-04
PL2001862T3 (pl) 2011-09-30
HRP20110558T1 (hr) 2011-09-30
CA2647346A1 (en) 2007-10-04
TW200808759A (en) 2008-02-16
AR060377A1 (es) 2008-06-11
DE602007014191D1 (en) 2011-06-09
SMP200800058B (it) 2009-09-07
AU2007230630A1 (en) 2007-10-04
ATE507219T1 (de) 2011-05-15
NZ570494A (en) 2011-09-30
KR20090004887A (ko) 2009-01-12
US20070232650A1 (en) 2007-10-04
ES2366150T3 (es) 2011-10-17
MA30554B1 (fr) 2009-07-01
KR101102288B1 (ko) 2012-01-03
SI2001862T1 (sl) 2011-10-28

Similar Documents

Publication Publication Date Title
PE20080175A1 (es) Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico
EA201270216A1 (ru) Фармацевтический состав
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
BR112015002821A8 (pt) compostos inibidores de neprilisina, composição farmacêutica e uso dos compostos
PE20121337A1 (es) Forma cristalina y amorfa de hemitartrato de genz 112638 como inhibidor de glucosilceramida sintasa
BR112013016595A2 (pt) inibidores de neprilisina
NI201200168A (es) Formulaciones farmacéuticas
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
PE20120083A1 (es) Sal monotosilato del compuesto 2-metil-2-[4-(3-metil-2-oxo-8-quinolin-3-il-2, 3-dihidro-imidazo-[4,5-c]-quinolin-1-il)-fenil]-propionitrilo en su forma cristalina a
BR112012018384A2 (pt) composição farmacêutica sólida com intensificadores e métodos de preparação da mesma.
MX2013007336A (es) Compuestos de bi-heteroarilo como inhibidores de vps34.
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA201070588A1 (ru) Производные 1,2,3-триазола для применения в качестве ингибиторов стеароил-соа десатуразы
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
BR112013029730A2 (pt) composição farmacêutica de rosuvastatina cálcica
BR112013018938A2 (pt) agente antifúngico tópico
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
EA201170101A1 (ru) Фармацевтические композиции роувастатина кальция
EP2152292A4 (en) ANGIOGENESIS HEMMER WITH METEORIN AS AN ACTIVE SUBSTANCE
UY34916A (es) "preparación sólida que contiene ácido[(3s)-6-){2´,6´-dimetil-4´-[3-(metilsulfonil)propoxi]bifenil-3-il}metoxi)-2,3-dihidro-1-benzofuran-3-il]acético"
BR112014016450A2 (pt) composto antagonista de leucotrieno b4
BRPI0713523A8 (pt) derivados de ácido fenilacético
EA201000882A1 (ru) Соединение, его применение и фармацевтическая композиция, содержащая это соединение
DK2293791T3 (da) Farmaceutiske præparater med entacapon co-mikroniseret med sukkeralkoholer

Legal Events

Date Code Title Description
FG Grant, registration